Medtech Insight is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Tengion (regenerative medicine) has raised $33mm through the closing of its Series C venture round. New investor Deerfield Partners was joined by returning backers Bain Capital, J&J Development Corp., HealthCap, Quaker BioVentures, Oak Investment Partners, and L Capital Partners. Tengion's current lenders, Horizon Technology and Oxford Finance, also made equity investments.
Gene Therapy, Cell Therapy
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?